Dr. Laura Ajram

Medicines Discovery Catapult

Improving translational research along the psychiatric drug discovery pipeline

Dr. Laura Ajram, Psychiatry Consortium Programme Manager at Medicines Discovery Catapult (MDC), discusses her work on the inception and management of MDC’s Psychiatry Consortium, a pioneering collaboration between medical charities, pharma and healthcare organizations focusing on novel drug discovery in mental health. Ajram, who won the prestigious 2021 ELRIG Early Career Impact Award 2021, sponsored by SelectScience, also shares her passion for meaningful research collaboration that could lead to drug discovery breakthroughs.



LIKE 1


Dr. Laura Ajram
Neuroscience Health Sciences

Dr. Laura Ajram

Biography

Dr. Laura Ajram, Psychiatry Consortium Programme Manager at Medicines Discovery Catapult More
Follow Laura

Dr. Laura Ajram

Medicines Discovery Catapult

Dr. Ajram gained her pharmacology degree at King's College London, which included a one-year industrial placement in respiratory pharmacology at GlaxoSmithKline, and went on to complete her Ph.D. in translational neuropharmacology at the Institute of Psychiatry (IoP), joint with Eli Lilly & Co in 2018. Dr. Ajram is currently the Programme Manager for the Psychiatry Consortium at Medicines Discovery Catapult, working with global pharmaceutical companies, research charities and contract research organizations to create a portfolio of projects to accelerate drug discovery in psychiatric disorders. Dr. Ajram is also an elected trustee of the British Pharmacological Society.